Medical Solutions expands genomics offerings with Autogen buy
This article was originally published in Clinica
In a move to expand its molecular diagnostics business, UK Medical Solutions has conditionally agreed to acquire Autogen Bioclear in an all-cash deal worth up to £6m ($12m). Calne, Wiltshire-based Autogen distributes diagnostic kits, antibodies, DNA clones and other products for genetic testing to the academic and charitably-funded research sectors. The company, which has nine employees, posted a turnover of £2.7m (+10%) for fiscal 2007, while pre-tax profits were up 47% at £823,000. Medical Solutions, based in Nottingham, said the acquisition would present cross-selling opportunities and cost savings, among other benefits.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.